Long COVID update: respiratory sequelae and symptoms
- PMID: 40170623
- DOI: 10.1097/SPC.0000000000000755
Long COVID update: respiratory sequelae and symptoms
Abstract
Purpose of review: Long COVID affects approximately 6% of the population after SARS-CoV-2 infection commonly involving persistent respiratory symptoms such as breathlessness and cough. This review provides an update on the latest evidence regarding post-COVID condition/Long COVID and respiratory sequelae, focusing on persistent symptoms, respiratory complications, and therapeutic approaches to date.
Recent findings: Post-COVID interstitial lung abnormalities are estimated to persist in approximately 11% of patients hospitalized with acute COVID-19. However, breathlessness is common in adults (non-hospitalized) with Long COVID, suggesting aetiologies beyond pneumonitis. The risk of venous thromboembolic disease in Long COVID remains uncertain and trial results of anti-coagulation in Long COVID are awaited.
Summary: Long COVID presents complex respiratory challenges, and careful assessment is crucial to differentiate Long COVID symptoms from exacerbations of pre-existing respiratory conditions. Current management includes a symptom-based multidisciplinary approach, with ongoing research into effective treatments including immune modulating agents.
Keywords: Long COVID; breathing-pattern disorder; breathlessness; post-COVID interstitial lung abnormality; rehabilitation; respiratory sequelae.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Office of National Statistics (ONS). Self-reported Coronavirus (COVID-19) Infections and Associated Symptoms, England and Scotland: November 2023 to March 2024. Office of National Statistics; 2024. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/... . [Accessed 12 February 2025].
-
- Thomas C, Faghy MA, Owen R, et al. Lived experience of patients with Long Covid: a qualitative study in the UK. BMJ Open 2023; 13:e068481.
-
- Brannock MD, Chew RF, Preiss AJ, et al. Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat Commun 2023; 14:2914.
-
- Roche N, Crichton ML, Goeminne PC, et al. Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur Respir J 2022; 60:2200803.
-
- Hastie CE, Lowe DJ, McAuley A, et al. True prevalence of long-COVID in a nationwide, population cohort study. Nat Commun 2023; 14:7892.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
